2022-2023 年報 Annual Report

醫療衞生服務 MEDICAL AND HEALTH SERVICES 37 While cancer is the top life-threatening killer across the territory, there are medications and therapies which can control the advancement of tumour, reduce relapse rate, increase the chance of survival or prolong patients’ life in modern medicine. Unfortunately, as the new medications and therapies are expensive self-financed items in public hospitals, some patients simply cannot afford them and subsequently lose the chance of receiving the therapy. Inspired by the Group’s tradition of free medical services, various generous donors initiated the setting up of “TWGHs MK Cancer Treatment Subsidy Fund”, which aims at providing support for needy cancer patients and their families in despair. TWGHs has set up the Management Committee and Assessment Panel for the Fund to monitor and assess applications. The Fund provides eligible breast cancer patients with clinical needs subsidies on neo-adjuvant double-target therapy currently not covered by the Government’s safety net, and patients’ attending doctors can recommend other subsidy items arisen from clinical needs for consideration by the Assessment Panel. The Fund was launched in 2017. As of January 2023, the Fund had subsidised 217 breast cancer patients to acquire self-financed medications for cancer treatment, with a total subsidy of around $30.33 million. Chinese medicine is good at strengthening and regulating the whole body, so that it can relieve treatment-related side effects in advanced cancer stages, enhance the immunity of cancer patients as well as improve their quality of life and long-term efficacy. In 2008, the Group established the “Chinese Medicine Cancer Treatment Assistance Fund” to provide financial assistance for eligible cancer patients to acquire services from Chinese medicine clinics and Chinese and Western medicine treatment centres, with an annual subsidy of approximately $2 million. As of December 2022, the Fund had approved around 600 applications this year. TWGHs allocated $1 million of public donation to sponsor half of the costs of basic rehabilitation treatment for eligible stoke patients. The project has started to accept application since June 2022, and so far it benefitted 4 patients over the past half year period. Starting from 2010, the “Renal Patient Assistance Fund” of the Group has been providing financial assistance for late stage renal failure patients to acquire haemodialysis treatments. More than $1.2 million is spent every year to subsidise around 4,500 haemodialysis treatments cases. A donation of $1 million was received to sponsor denture making for the eligible elderly. The project has started to accept application since December 2021, and as of December 2022 it has benefitted a total of 116 elderly. 雖然癌症是香港的頭號殺手,但現代醫學有不 少有效藥物及療法可以抑制腫瘤生長、減低復 發率、增加患者生存機會或延長患者壽命。 可惜新藥物及療法價格高昂,在公立醫院屬於 自資購買的醫療項目,部分病人因未能負擔而 失去治療機會。有見及此,善心人士發起成立 「東華三院樂儀癌病治療資助基金」,秉承 東華三院贈醫施藥的傳統,讓患者及家屬在危病 徬徨中得到支援。本院設有基金管理委員會及審 批小組,監察及審批基金的申請。基金為有臨床 需要及符合資格的乳癌病人,提供政府安全網未 能資助的手術前雙標靶治療,其他資助項目將按 病人的臨床需要,由主診醫生推薦並由基金設 立的評審小組審批。基金於2017 年推行,截至 2023 年1 月,基金共資助了217 名乳癌病人購買 自費治癌藥物,資助總額大概為3,033 萬元。 中醫善於扶正固本,全身調理,能改善中晚期癌 症治的不適症,增強患者免疫力,提高生活質素 及長期療效。為協助有經濟困難的腫瘤科病人接 受中醫治療,本院於2008 年成立「中醫癌症治療 助醫計劃」,資助合資格病人使用中醫門診及中 西醫藥治療中心服務的費用,每年資助額約200 萬元。截至2022 年12 月,該計劃本年度共批核 大約600 宗個案。 本院撥出100 萬元捐款於2022 年6 月成立「中風 人士復康資助計劃」,為合資格的申請者提供基 本治療費半額資助,半年間共有4 位人士受惠。 由2010 年開始,本院的「腎病病人助醫計劃」 每年資助末期腎衰竭病人接受血液透析治療,每 年支出超過120 萬元,資助約4,500 宗血液透析 服務。 本院獲得善長100 萬元捐款,資助有需要的長者 鑲配活動假牙。資助計劃於2021 年12 月開始接 受申請,至2022 年12 月共有116 位長者受惠。 設立東華三院樂儀癌病治療資助基金 中醫癌症治療助醫計劃 中風人士復康資助計劃 腎病病人助醫計劃 長者免費鑲配活動假牙計劃 Setting up TWGHs MK Cancer Treatment Subsidy Fund Chinese Medicine Cancer Treatment Assistance Fund Rehabilitation Sponsorship Scheme for Stroke Patients Renal Patient Assistance Fund Denture Sponsorship Scheme for the Elderly TWGHs fully supports the concept of a holistic approach to treatment, in which patients’ physical pain, psychological and spiritual discomfort and the stress caused by illnesses can all be well addressed. TWGHs Board of Directors allocated funding to subsidise patient support groups of the Group’s hospitals to organise health education and social activities for patients to facilitate mutual support and sharing among patients and their families. These support groups include the mutual aid groups formed by patients of renal diseases, diabetic mellitus, breast cancer, stroke and systemic lupus erythematosus, etc. 本院非常支持全人治療,包括身、心、靈的治療, 因為病人除了身體上承受痛楚外,還要處理心靈 以至精神上所承受的壓力與情緒問題。因此, 東華三院董事局撥款資助屬下醫院的病人互助組 織舉辦不同的健康教育和社交活動,讓患者及家 人互相交流、互相扶持,其中包括腎病、糖尿病、 乳癌、中風及紅斑狼瘡等病人互助小組。 病人互助組織 Patient Support Groups

RkJQdWJsaXNoZXIy MTkxODY5Mg==